, Tracking Stock Market Picks
Enter Symbol:
Endologix Inc (ELGX) [hlAlert]

up 83.30 %

Endologix Inc (ELGX) rated Outperform with price target $9 by Robert W. Baird

Posted on: Friday,  Jan 14, 2011  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Endologix Inc (NASDAQ: ELGX) on 01/14/2011, when the stock price was $7.07.
Since then, Endologix Inc has gained 83.31% as of 01/14/2016's recent price of $12.96.
If you would have followed this Robert W. Baird's recommendation on ELGX, you would have gained 83.3% of your investment in 1826 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2011 8:25 AM Buy
7.07 9.00
as of 12/30/2011
1 Week down  -0.60 %
1 Month up  1.23 %
3 Months up  14.34 %
1 YTD up  62.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy